TLneoCare, LLC
Improving Infant Care to Save Lives
TLneoCare is developing a first in its class device that will bring a life saving therapy into the neonatal intensive care unit (NICU) to potentially save the lives of thousands of infants a year.
TLneoCare's patent-pending medical technology will provide a novel solution
to the problem of implementing infant massage into the NICU, while improving
the quality of care. TLneoCare's innovation is based on scientifically
proven research which shows that infant massage increases the survival rate
of premature infants by 30% by increasing their growth rate and reducing
their hospital stay by up to 6 days per infant.
Feedback from doctors (neonatologists) and neonatal nurses has been positive
and enthusiastic.
Among TLneoCare’s primary advantages in developing and commercializing this medical innovation include:
- Strong IP protection
- Pre-existing applicable insurance re-imbursement codes
- Anticipated 510K FDA process
- High volume consumable
- Expansion to a large consumer market for infant products that is not FDA regulated.
The TLneoCare’s team is currently working on securing financing to bring the technology to market.
Press Releases
- TLneoCare took top place at the Wake Forest Elevator Pitch Competition in 2007.
- TLneoCare was awarded “Outstanding Market Award” at the Global Moot Business Plan Competition in 2007
TLneoCare’s Team
Sanna Gaspard
PhD candidate BME at Carnegie Mellon University Founder, Chief Scientific & Technical Officer
Tom Matt
MBA (Tepper 07) Chief Financial & Operations Officer
  Health |
  Societal Good |
